Prostate Cancer Detection - Endotext - NCBI Bookshelf
SciELO - Brazil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
Prostatic specific antigen for prostate cancer detection
JKMS :: Journal of Korean Medical Science
Pituitary Evaluation in Patients with Low Prostate-Specific Antigen - Endocrine Practice
Age, prostate volume, and PSA results of 212 patients diagnosed with... | Download Table
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
Analysis of the serum prostate-specific antigen level (mean ng/mL ±... | Download Table
The average PSA level (ng / ml) in patients with PCa, depending on... | Download Scientific Diagram
International Braz J Urol ::
Single Screening for PSA Levels Does Not Improve Survival in Prostate Cancer - Oncology Nurse Advisor
Rising PSA Level in an Anxious Postprostatectomy Patient
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - ScienceDirect
